Johnson & Johnson (JNJ) Current Taxes (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Current Taxes came in at $1.1 billion in Q1 2026, down 74.22% year-on-year from $4.2 billion in Q1 2025, and down 21.69% quarter-over-quarter from $1.4 billion in Q4 2025.

Johnson & Johnson (JNJ) Current Taxes (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Current Taxes across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

  • Current Taxes for Q1 2026 came in at $1.1 billion, down 74.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 74.22% YoY), and the FY2025 annual result was $1.4 billion, down 63.2% from the prior year.
  • Current Taxes came in at $1.1 billion for Q1 2026 at Johnson & Johnson, down from $1.4 billion in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $4.8 billion in Q3 2024 to a low of $1.1 billion in Q1 2026.
  • The 5-year median for Current Taxes is $2.5 billion (2023), against an average of $2.7 billion.
  • Across the five-year window, Current Taxes surged 149.77% in 2023 and sank 74.22% in 2026, its largest moves.
  • Johnson & Johnson's Current Taxes stood at $2.0 billion in 2022, then soared by 50.7% to $3.0 billion in 2023, then climbed by 26.03% to $3.8 billion in 2024, then sank by 63.2% to $1.4 billion in 2025, then decreased by 21.69% to $1.1 billion in 2026.
  • The last three Current Taxes figures came in at $1.1 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -748.24 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 1.09 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 3.95 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 3.13 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 1.09 Bn
Dec 28, 2025 1.39 Bn
Sep 28, 2025 1.93 Bn
Jun 29, 2025 1.67 Bn
Mar 30, 2025 4.22 Bn
Dec 29, 2024 3.77 Bn
Sep 29, 2024 4.83 Bn
Jun 30, 2024 4.31 Bn
Mar 31, 2024 3.32 Bn
Dec 31, 2023 2.99 Bn
Oct 1, 2023 2.90 Bn
Jul 2, 2023 2.69 Bn
Apr 2, 2023 4.27 Bn
Jan 1, 2023 2.22 Bn
Oct 2, 2022 1.99 Bn
Jul 3, 2022 1.98 Bn
Apr 3, 2022 1.71 Bn
Jan 2, 2022 1.11 Bn
Oct 3, 2021 2.16 Bn
Jul 4, 2021 1.20 Bn